Cell MedX Corp. - FORM 10-K - EX-32.1 - CERTIFICATION - September 13, 2016

Attached files

file filename
EX-10.41 - LOAN AGREEMENT AND NOTE PAYABLE DATED JUNE 29, 2016, AMONG CELL MEDX CORP., AND TRADEX CAPITAL CORP. - Cell MedX Corp.ex1041.htm
10-K - 10-K - Cell MedX Corp.form10k.htm
EX-32.1 - CERTIFICATION - Cell MedX Corp.ex322.htm
EX-31.2 - CERTIFICATION - Cell MedX Corp.ex312.htm
EX-31.1 - CERTIFICATION - Cell MedX Corp.ex311.htm
EX-21.0 - LIST OF SUBSIDIARIES. - Cell MedX Corp.ex21.htm
EX-10.44 - LOAN AGREEMENT AND NOTE PAYABLE DATED AUGUST 22, 2016, AMONG CELL MEDX CORP., AND TRADEX CAPITAL CORP. - Cell MedX Corp.ex1044.htm
EX-10.43 - LOAN AGREEMENT AND NOTE PAYABLE DATED AUGUST 8, 2016, AMONG CELL MEDX CORP., AND RICHARD N. JEFFS. - Cell MedX Corp.ex1043.htm
EX-10.42 - LOAN AGREEMENT AND NOTE PAYABLE DATED JUNE 30, 2016, AMONG CELL MEDX CORP., AND RICHARD N. JEFFS. - Cell MedX Corp.ex1042.htm
EX-10.40 - LOAN AGREEMENT AND NOTE PAYABLE DATED JUNE 2, 2016, AMONG CELL MEDX CORP., AND RICHARD N. JEFFS. - Cell MedX Corp.ex1040.htm
EX-10.39 - LOAN AGREEMENT AND NOTE PAYABLE DATED JUNE 1, 2016, AMONG CELL MEDX CORP., AND TRADEX CAPITAL CORP. - Cell MedX Corp.ex1039.htm
EX-10.38 - LOAN AGREEMENT AND NOTE PAYABLE DATED APRIL 29, 2016, AMONG CELL MEDX CORP., AND RICHARD N. JEFFS. - Cell MedX Corp.ex1038.htm
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 

 
 
In connection with the Annual Report of Cell MedX Corp. (the “Company”) on Form 10-K for the period ending May 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Frank McEnulty, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
 
(1)   The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 
(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Dated: September 13, 2016
 
 
/s/Frank McEnulty
___________________________
 
 
Frank McEnulty
Chief Executive Officer
 

 
 
 

Cell MedX Corp. Reports